ArticleJournal of functional biomaterials2025
Electrospun Polycaprolactone-Gelatin Fibrils Enabled 3D Hydrogel Microcapsules for Biomedical Applications.
Article in Journal of functional biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Microcapsules provide a microenvironment by improving the protection and delivery of cells and drugs to specific tissue areas, promoting cell integration and tissue regeneration. Effective microcapsules must not only be permeable for micronutrient diffusion but mechanically stable. Alginate hydrogel is one of the commonly used biomaterials for fabricating microcapsules due to its gel-forming ability and low toxicity. However, its mechanical instability, inertness, and excessive porosity have impeded its use. Embedding nanofibrils in the alginate hydrogel microcapsules improves their biological and mechanical properties. In this research, electrospun composite nanofibers of PCL-gelatin (PG) were first fabricated, characterized, and cryoground. The filtered and cryoground powder solution was mixed with the alginate solution and through electrospray, fabricated into microcapsules. Parameters such as flow rate, voltage, and hydrogel composition, which are critical in the electrostatic encapsulation process, were optimized. The microcapsules were further immersed in different solvent environments (DI water, complete media, and PBS), which were observed and compared for their morphology, size distribution, and mechanical stability properties. The average diameters of the PG nanofibers ranged between 0.2 and 2 μm, with an average porosity between 58 and 73%. The average size of the microcapsules varied between 300 and 900 μm, depending on the solvent environment. Overall, results showed an improved alginate 3D hydrogel network suitable for biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.